Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation

Summary Downregulation of adherens junction proteins is a frequent event in carcinogenesis. How desmosomal proteins contribute to tumor formation by regulating the balance between adhesion and proliferation is not well understood. The desmosomal protein plakophilin 1 can increase intercellular adhesion by recruiting desmosomal proteins to the plasma membrane or stimulate proliferation by enhancing translation rates. Here, we show that these dual functions of plakophilin 1 are regulated by growth factor signaling. Insulin stimulation induced the phosphorylation of plakophilin 1, which correlated with reduced intercellular adhesion and an increased activity of plakophilin 1 in the stimulation of translation. Phosphorylation was mediated by Akt2 at four motifs within the plakophilin 1 N-terminal domain. A plakophilin 1 phospho-mimetic mutant revealed reduced intercellular adhesion and accumulated in the cytoplasm, where it increased translation and proliferation rates and conferred the capacity of anchorage-independent growth. The cytoplasmic accumulation was mediated by the stabilization of phosphorylated plakophilin 1, which displayed a considerably increased half-life, whereas non-phosphorylated plakophilin 1 was more rapidly degraded. Our data indicate that upon activation of growth factor signaling, plakophilin 1 switches from a desmosome-associated growth-inhibiting to a cytoplasmic proliferation-promoting function. This supports the view that the deregulation of plakophilin 1, as observed in several tumors, directly contributes to hyperproliferation and carcinogenesis in a context-dependent manner.

[1]  R. Gillies,et al.  Determination of cell number in monolayer cultures. , 1986, Analytical biochemistry.

[2]  R. Moll,et al.  Desmosomal proteins: new markers for identification and classification of tumors. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[3]  E. Lane,et al.  Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome , 1997, Nature Genetics.

[4]  D. Garrod,et al.  Desmosomal adhesion inhibits invasive behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Rosen,et al.  Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.

[6]  G. Lyons,et al.  Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin , 1998, Oncogene.

[7]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.

[8]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[9]  W. Sellers,et al.  Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Lake,et al.  Skin fragility and hypohidrotic ectodermal dysplasia resulting from ablation of plakophilin 1 , 1999, The British journal of dermatology.

[11]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[12]  K. Green,et al.  The Head Domain of Plakophilin-1 Binds to Desmoplakin and Enhances Its Recruitment to Desmosomes , 1999, The Journal of Biological Chemistry.

[13]  R. Weigel,et al.  Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. , 1999, Biochemical and biophysical research communications.

[14]  J. Behrens,et al.  Control of beta-catenin signaling in tumor development. , 2000, Annals of the New York Academy of Sciences.

[15]  D. Sivam,et al.  Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis , 2000, The Laryngoscope.

[16]  J. Behrens,et al.  Control of β‐Catenin Signaling in Tumor Development , 2000 .

[17]  P. Polakis Wnt signaling and cancer. , 2000, Genes & development.

[18]  E. Fearon,et al.  gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. , 2000, Genes & development.

[19]  M. Schnölzer,et al.  Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. , 2000, Journal of cell science.

[20]  Kathleen R. Cho,et al.  γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin , 2000, Genes & Development.

[21]  M. Pasdar,et al.  Plakoglobin Regulates the Expression of the Anti-apoptotic Protein BCL-2* , 2000, The Journal of Biological Chemistry.

[22]  C. Haffner,et al.  The Function of Plakophilin 1 in Desmosome Assembly and Actin Filament Organization , 2000, The Journal of cell biology.

[23]  M. Hentze,et al.  Lipoxygenase mRNA Silencing in Erythroid Differentiation The 3′UTR Regulatory Complex Controls 60S Ribosomal Subunit Joining , 2001, Cell.

[24]  F. van Roy,et al.  Protein Binding and Functional Characterization of Plakophilin 2 , 2002, The Journal of Biological Chemistry.

[25]  Y. Miller,et al.  γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth , 2002, Oncogene.

[26]  Jennifer Skeen,et al.  Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.

[27]  J. McGrath,et al.  Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability , 2003, Journal of Cell Science.

[28]  F. van Roy,et al.  Defining desmosomal plakophilin-3 interactions , 2003, The Journal of cell biology.

[29]  H. Kurzen,et al.  Expression of desmosomal proteins in squamous cell carcinomas of the skin , 2003, Journal of cutaneous pathology.

[30]  P. Vogt,et al.  An essential role for protein synthesis in oncogenic cellular transformation , 2004, Oncogene.

[31]  M. Stack,et al.  Epidermal Growth Factor Receptor Inhibition Promotes Desmosome Assembly and Strengthens Intercellular Adhesion in Squamous Cell Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[32]  A. South Plakophilin 1: an important stabilizer of desmosomes , 2004, Clinical and experimental dermatology.

[33]  A. Gingras,et al.  Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases , 2004, The EMBO journal.

[34]  Peter J Houghton,et al.  Lost in translation: dysregulation of cap-dependent translation and cancer. , 2004, Cancer cell.

[35]  J. Cheng,et al.  Deregulated Akt3 Activity Promotes Development of Malignant Melanoma , 2004, Cancer Research.

[36]  G. Robertson Functional and therapeutic significance of Akt deregulation in malignant melanoma , 2005, Cancer and Metastasis Reviews.

[37]  R. Bergman,et al.  Histopathological and Ultrastructural Study of Ectodermal Dysplasia/Skin Fragility Syndrome , 2005, The American Journal of dermatopathology.

[38]  M. Oshimura,et al.  PI3K-Akt pathway: Its functions and alterations in human cancer , 2004, Apoptosis.

[39]  M. Hatzfeld The p120 family of cell adhesion molecules. , 2005, European journal of cell biology.

[40]  Yusuke Nakamura,et al.  Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. , 2005, Cancer research.

[41]  J. McGrath,et al.  Ectodermal dysplasia-skin fragility syndrome resulting from a new homozygous mutation, 888delC, in the desmosomal protein plakophilin 1. , 2006, Journal of the American Academy of Dermatology.

[42]  Walter Birchmeier,et al.  Balancing cell adhesion and Wnt signaling, the key role of β-catenin , 2006 .

[43]  H. Spring,et al.  Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. , 2005, Molecular biology of the cell.

[44]  H. Clevers Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[45]  N. Sonenberg,et al.  mTOR, translation initiation and cancer , 2006, Oncogene.

[46]  Walter Birchmeier,et al.  Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. , 2006, Current opinion in genetics & development.

[47]  W. Peitsch,et al.  Homo- and heterotypic cell contacts in malignant melanoma cells and desmoglein 2 as a novel solitary surface glycoprotein. , 2007, The Journal of investigative dermatology.

[48]  M. Ozawa,et al.  Increased Internalization of p120-uncoupled E-cadherin and a Requirement for a Dileucine Motif in the Cytoplasmic Domain for Endocytosis of the Protein* , 2007, Journal of Biological Chemistry.

[49]  J. Hardin,et al.  Making and breaking contacts: the cellular biology of cadherin regulation. , 2007, Current opinion in cell biology.

[50]  C. Dawson,et al.  Desmosomes: a role in cancer? , 2007, British Journal of Cancer.

[51]  M. Ladanyi,et al.  Novel Markers of Subclinical Disease for Ewing Family Tumors from Gene Expression Profiling , 2007, Clinical Cancer Research.

[52]  M. Hatzfeld Plakophilins: Multifunctional proteins or just regulators of desmosomal adhesion? , 2007, Biochimica et biophysica acta.

[53]  F. van Roy,et al.  Plakophilin-3-deficient mice develop hair coat abnormalities and are prone to cutaneous inflammation. , 2008, The Journal of investigative dermatology.

[54]  M. Mann,et al.  Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. , 2008, Journal of proteome research.

[55]  Massimo Libra,et al.  Akt as a therapeutic target in cancer. , 2008, Expert opinion on therapeutic targets.

[56]  Yoshihiro Kakeji,et al.  Deregulation of the Akt pathway in human cancer. , 2008, Current cancer drug targets.

[57]  V. Faundez,et al.  Pemphigus Vulgaris IgG-induced Desmoglein-3 Endocytosis and Desmosomal Disassembly Are Mediated by a Clathrin- and Dynamin-independent Mechanism* , 2008, Journal of Biological Chemistry.

[58]  J. Decaprio,et al.  Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis , 2008, International journal of cancer.

[59]  S. Sheng,et al.  Metastasis and AKT activation , 2008, Cell cycle.

[60]  W. Peitsch,et al.  Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins , 2008, Cell and Tissue Research.

[61]  W. Kong,et al.  Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. , 2008, Current cancer drug targets.

[62]  L. Godsel,et al.  Plakophilins: multifunctional scaffolds for adhesion and signaling. , 2009, Current opinion in cell biology.

[63]  R. Memmott,et al.  Akt-dependent and -independent mechanisms of mTOR regulation in cancer. , 2009, Cellular signalling.

[64]  M. Hatzfeld,et al.  Targeting of p0071 to the midbody depends on KIF3 , 2009, Journal of Cell Science.

[65]  R. Windoffer,et al.  Desmosome Assembly and Cell-Cell Adhesion Are Membrane Raft-dependent Processes , 2010, The Journal of Biological Chemistry.

[66]  Q. She,et al.  4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. , 2010, Cancer cell.

[67]  R. Moll,et al.  The Desmosomal Plaque Proteins of the Plakophilin Family , 2010, Dermatology research and practice.

[68]  N. Narayana,et al.  Desmosomal Component Expression in Normal, Dysplastic, and Oral Squamous Cell Carcinoma , 2010, Dermatology research and practice.

[69]  Kyucheol Cho,et al.  Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members , 2010, Journal of Cell Science.

[70]  B. Wall,et al.  AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1) , 2010, Pigment cell & melanoma research.

[71]  Brett J. Roberts,et al.  Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. , 2010, The Journal of investigative dermatology.

[72]  Angélica Figueroa,et al.  Evaluation of Plakophilin-3 mRNA as a Biomarker for Detection of Circulating Tumor Cells in Gastrointestinal Cancer Patients , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[73]  M. Hatzfeld,et al.  A role of plakophilins in the regulation of translation , 2010, Cell cycle.

[74]  Olaf Birkenmeier,et al.  Plakophilin 1 stimulates translation by promoting eIF4A1 activity , 2010, The Journal of cell biology.

[75]  Soonjin Hong,et al.  Spontaneous assembly and active disassembly balance adherens junction homeostasis , 2010, Proceedings of the National Academy of Sciences.

[76]  Vijay Adhe,et al.  Ectodermal dysplasia-skin fragility syndrome. , 2011, Indian journal of dermatology, venereology and leprology.

[77]  L. Attardi,et al.  Desmosomes: new perpetrators in tumour suppression , 2011, Nature Reviews Cancer.

[78]  Y. Hanakawa,et al.  Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. , 2011, The Journal of investigative dermatology.

[79]  S. Peltonen,et al.  A role for caveolin-1 in desmoglein binding and desmosome dynamics , 2011, Oncogene.

[80]  A. Ciliberto,et al.  Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. , 2012, Physiological reviews.

[81]  Stefan Posch,et al.  Cell migration analysis: Segmenting scratch assay images with level sets and support vector machines , 2012, Pattern Recognit..